aztreonam has been researched along with Acquired Meningocele in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigaré, M | 1 |
| Lesaffre, X | 1 |
| Delassus, JL | 1 |
| Bakir, R | 1 |
| Bouldouyre, MA | 1 |
1 other study available for aztreonam and Acquired Meningocele
| Article | Year |
|---|---|
[Relapse of Escherichia coli meningitidis due to sacral meningocele in Marfan syndrome, treated only with antibiotherapy].
Topics: Abnormalities, Multiple; Anti-Bacterial Agents; Aztreonam; Escherichia coli; Female; Humans; Magneti | 2014 |